A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
12don MSN
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Arizona universities, researchers wait to learn their funding future during NIH communication freeze
A Trump administration order to freeze communication at the National Institutes of Health has disrupted scientific research ...
The White House budget office rescinded the funding freeze, but Trump will still attempt to pull back funding from “woke” ...
National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...
Princeton received fewer awards in the past two fiscal years of 2023 and 2024 than in every year since 2011 and less funding ...
During the pandemic, Matthew Memoli, who has conducted research on influenza and other viruses, was also a vocal critic of Anthony Fauci, who for decades served as the director of the National ...
13don MSN
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
the acting director of the N.I.H., Dr. Matthew Memoli, said in an email to staff on Monday. While Dr. Memoli’s announcement provided some clarification, it left many questions unanswered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback